These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 11795015)
1. [Long-term results of an eradication regime against Staphylococcus aureus in patients treated with peritoneal dialysis]. Cancho B; Garduño E; Domínguez C; Blanco J; Caravaca F Nefrologia; 2001; 21(5):464-70. PubMed ID: 11795015 [TBL] [Abstract][Full Text] [Related]
2. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience. Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916 [TBL] [Abstract][Full Text] [Related]
3. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306 [TBL] [Abstract][Full Text] [Related]
4. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site. Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524 [TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis. Kingwatanakul P; Warady BA Adv Perit Dial; 1997; 13():281-4. PubMed ID: 9360700 [TBL] [Abstract][Full Text] [Related]
6. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis. Mahaldar A; Weisz M; Kathuria P Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318 [TBL] [Abstract][Full Text] [Related]
7. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881 [TBL] [Abstract][Full Text] [Related]
8. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441 [TBL] [Abstract][Full Text] [Related]
9. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Xu G; Tu W; Xu C Nephrol Dial Transplant; 2010 Feb; 25(2):587-92. PubMed ID: 19679557 [TBL] [Abstract][Full Text] [Related]
10. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309 [TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus infections during peritoneal dialysis. Coles GA J Chemother; 1995 Jul; 7 Suppl 3():67-70. PubMed ID: 8609540 [TBL] [Abstract][Full Text] [Related]
12. The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital. Lim CT; Wong KS; Foo MW Nephrol Dial Transplant; 2005 Oct; 20(10):2202-6. PubMed ID: 16046516 [TBL] [Abstract][Full Text] [Related]
13. A ten-year single-centre experience in children on chronic peritoneal dialysis--significance of percutaneous placement of peritoneal dialysis catheters. Aksu N; Yavascan O; Anil M; Kara OD; Erdogan H; Bal A Nephrol Dial Transplant; 2007 Jul; 22(7):2045-51. PubMed ID: 17438008 [TBL] [Abstract][Full Text] [Related]
14. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital. Lim CT; Wong KS; Foo MW Nephrol Dial Transplant; 2005 Aug; 20(8):1702-6. PubMed ID: 15855200 [TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071 [TBL] [Abstract][Full Text] [Related]
16. Exit site infections: systematic microbiologic and quality control are needed. Freitas C; Rodrigues A; Carvalho MJ; Cabrita A Adv Perit Dial; 2009; 25():26-31. PubMed ID: 19886313 [TBL] [Abstract][Full Text] [Related]
17. Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience. Aykut S; Caner C; Ozkan G; Ali C; Tugba A; Zeynep G; Taner C Ren Fail; 2010 Jan; 32(3):356-61. PubMed ID: 20370452 [TBL] [Abstract][Full Text] [Related]
18. [Staphylococcus aureus colonization and risk of developing a subsequent peritonitis episode caused by an identical strain, among pediatric patients admitted for continuous ambulatory peritoneal dialysis]. Miranda-Novales G; Aburto y-Huesca R; Leaños-Miranda B; Mendoza-Guevara L; Paniagua R; Amato D Gac Med Mex; 2008; 144(4):297-302. PubMed ID: 18942263 [TBL] [Abstract][Full Text] [Related]
19. An integrated critique of the efficacy of topical mupirocin in preventing catheter-related Staphylococcus aureus infections in peritoneal dialysis clients. Pratt O CANNT J; 2002; 12(1):20-8. PubMed ID: 11979650 [TBL] [Abstract][Full Text] [Related]
20. [Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines]. Kopriva-Altfahrt G; Moser E; Prokschi A; Kraus B; Kovarik J Wien Klin Wochenschr; 2005; 117 Suppl 6():73-82. PubMed ID: 16437337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]